Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose–response meta‐analysis

Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose–response meta‐analysis

Abstract Background Worse prognosis of endometrial cancers (EC) in tamoxifen‐treated women compared to non‐tamoxifen‐treated women been proposed. The relationship between tamoxifen treatment of breast cancer (BC) and the risk of EC is controversial and there is no agreement between publication resul...

Full description

Bibliographic Details
Main Authors: Matin Ghanavati, Yasaman Khorshidi, Mahdi Shadnoush, Mohammad Esmaeil Akbari, Seyed Hossein Ardehali, Yanin Chavarri‐Guerra, Atieh Akbari, Regina Barragan‐Carrillo, Manoochehr Amin Amlashi, Zeinab Javid, Jamal Rahmani
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Cancer Reports
Subjects:
breast cancer
dose–response
endometrial cancer
tamoxifen
Online Access:https://doi.org/10.1002/cnr2.1806

Internet

https://doi.org/10.1002/cnr2.1806

Similar Items